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Depression: an exploratory parallel-group
randomised controlled trial of Antenatal
guided self help for WomeN (DAWN): study
protocol for a randomised controlled trial
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Abstract
Background: Depression is a common antenatal mental disorder and is associated with an increased risk of adverse
effects on the fetus and significant morbidity for the mother; if untreated it can also continue into the post-natal
period and affect mother-infant interactions. There has been little research evaluating the effectiveness or cost-effectiveness
of antenatal psychological interventions for antenatal depression, particularly for mild to moderate disorders. International
guidelines recommend a stepped care approach starting with Guided Self Help, and the aim of this exploratory trial is to
investigate Guided Self Help modified for pregnancy.
Methods: The DAWN trial is an exploratory randomised controlled trial of the effectiveness and cost-effectiveness
of antenatal Guided Self Help, modified for pregnancy and delivered by National Health Service Psychological
Wellbeing Practitioners. Antenatal Guided Self Help, in addition to usual care, is compared with usual care for
pregnant women diagnosed with mild to moderate depression and mixed anxiety and depression, using the
Structured Clinical Interview for DSM-IV Disorders. Modifications for pregnancy include perinatal mental health
training, addressing pregnancy-specific worries and including sections on health issues in pregnancy and planning for
parenthood. Women allocated to Guided Self Help will be seen for up to eight sessions by a Psychological Wellbeing
Practitioner (including an initial assessment session); there will also be an appointment at 12 weeks after delivery.
Research measures including the Edinburgh Postnatal Depression Scale (primary outcome) and other measures of
depression, anxiety, quality of life and service use will be collected from women before random allocation, 14 weeks
after random allocation and at 12 weeks after delivery. Potential psychological mechanisms of the intervention will be
explored using the Pregnancy-Related Thoughts Questionnaire and the Metacognitive Awareness Questionnaire.
Discussion: The DAWN trial is the first exploratory trial to investigate the efficacy of antenatal Guided Self Help for
pregnant women with mild to moderate depression meeting DSM-IV diagnostic criteria. Recruitment started January
2015 and is expected to be completed by July 2016.
Trial registration: ISRCTN registry: ISRCTN83768230. Registered on 8 August 2014.
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Background
Pregnancy does not appear to be protective against the
persistence or development of psychiatric disorders [1].
Depression is the most common antenatal mental dis-
order with a 9 % period prevalence [1], which is similar
to that for non-pregnant childbearing-aged women. De-
pression in pregnancy can have a considerable impact
upon the woman and her family, and is associated with
an increased risk of (1) adverse effects on the fetus, in-
cluding low birth weight and preterm delivery [2]; (2) in-
fant deaths [3]; (3) post-natal maternal psychopathology
[4–6]; (4) subsequent behavioural/emotional problems in
the child and adolescent [7]; and (5) negative impacts on
other family members [8]. Such adverse outcomes are
not inevitable, and early effective interventions could
mitigate these effects. Since mental disorders in preg-
nancy are also associated with other risk factors that
may lead to adverse outcomes, particularly smoking
[9, 10], socio-economic deprivation [11], obesity [12]
and domestic violence [13, 14], consideration of associated
risk factors should also be included in the development of
interventions. International guidelines recommend that
there should be a higher threshold for medication than at
other times in a woman’s life due to the potential risk
to the fetus, as well as a lower threshold for offering
psychological therapies [15]. To date there has been
little research evaluating the effectiveness of antenatal
psychological interventions for the most common dis-
order: mild and moderate antenatal depression.
Cochrane reviews have reported limited evidence on
the effectiveness of small trials of interpersonal therapy,
massage and acupuncture [16, 17], and there have only
been three recently completed pilot randomised con-
trolled trials of cognitive behavioural therapy (CBT)
[18–20]. To our knowledge, there has been no evalu-
ation of less intensive psychological interventions for
women diagnosed with mild and moderate depression in
the antenatal setting — interventions which may be
more cost-effective.
The National Institute for Health and Care Excellence
(NICE) [15] recommends a stepped care approach for de-
pression, starting with Guided Self Help, a low-cost inter-
vention for mild and moderate depression which is
delivered by Psychological Wellbeing Practitioners. Recent
UK national policy highlights the importance of improving
access to psychological therapies for women in the peri-
natal period [21]. A recent systematic review and meta-
analysis of Guided Self Help for mild and moderate
depression found evidence of effectiveness post-treatment
but limited effectiveness at long-term follow-up, with vari-
ability across different settings [22]; no trials in perinatal
settings were included. However, an Australian study of
an antenatal supported self help intervention for the pre-
vention of perinatal common mental symptoms reported
reduced depressive symptoms at 12 weeks post-delivery
[23]. Moreover, in the antenatal period even short-term
improvement in mild disorders is important, as there is
evidence that mild disorders can adversely affect fetal out-
comes [2]. Although psychological interventions in the
antenatal setting which are less intensive may be more
cost-effective for mild and moderate antenatal depression,
there has been no evaluation of this approach. We there-
fore propose to evaluate a new form of Guided Self Help
for antenatal depression in women using UK National
Health Service (NHS) maternity services in an exploratory
randomised controlled trial (RCT).
The objectives of this exploratory trial are to:
1. Establish recruitment and follow-up rates
2. Indicate levels of compliance with the intervention
3. Indicate for whom the intervention is most suitable
4. Provide preliminary evidence for the efficacy of the
intervention (estimating treatment effect sizes)
5. Provide preliminary evidence for the cost-effectiveness
of the intervention compared to usual care
6. Explore the psychological mechanisms of the
intervention.
We will test our procedures within large maternity ser-
vices in English NHS settings [24]. The NHS is the pub-
licly funded healthcare system for England. It provides
healthcare to every legal resident in the United Kingdom,
with mental health and primary care among the services
free at the point of use.
There are four specific main aims of this trial: (1) to
establish that the trial procedures work (and fine-tune
where necessary) so that a Phase III trial can follow; (2)
to evaluate whether antenatal Guided Self Help is bene-
ficial in improving depressive symptoms for women with
antenatal depression; (3) to evaluate whether antenatal
Guided Self Help has the added benefit of improving
other outcomes, including post-treatment and post-
delivery psychological symptoms, post-delivery bonding
and quality of life; and (4) to explore whether antenatal
Guided Self Help is likely to be cost-effective compared
to usual care. The latter two aims will also estimate
treatment effect sizes.
The following hypothesis will be tested:
Women with mild or moderate antenatal depression
treated with Guided Self Help will have significantly lower
Edinburgh Postnatal Depression Scale (EPDS) depressive
symptoms at 14 weeks post-randomisation compared to
women with mild or moderate antenatal depression re-
ceiving usual care.
Methods/design
This study has been designed according to the Standard
Protocol Items: Recommendations for Interventional
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Trials (SPIRIT) statement. Additional file 1: Table S1
presents the SPIRIT checklist, and Additional file 2:
Figure S1 presents the SPIRIT figure for the schedule
of enrolment, intervention and assessments.
The trial is a multi-centre Phase II exploratory rando-
mised controlled trial with two parallel groups and a pri-
mary endpoint of EPDS depressive symptoms at 14 weeks
post-randomisation.
Pregnant women with depression will be randomly al-
located to either Guided Self Help plus usual care or to
usual care alone (i.e. treatment as usual). Randomisa-
tion, stratified by type of depression (i.e. mild or mod-
erate depression, or mixed anxiety and depression), will
be performed using block randomisation of varying
sizes with a 1:1 allocation.
Study setting
The study setting is inner city English NHS maternity
services in South East London serving an ethnically and
socially diverse population.
Eligibility criteria
Inclusion criteria
Women must have the following characteristics prior to
randomisation:
1. Aged ≥16 years
2. Pregnant, not exceeding 26 weeks gestation
3. Meet criteria for Diagnostic and Statistical Manual
of Mental Disorders (DSM)-IV depression (mild or
moderate major depressive disorder, or mixed
anxiety and depressive disorder) on the Structured
Clinical Interview DSM-IV (SCID)
4. Able to provide informed consent.
Exclusion criteria
The exclusion criteria are as follows:
1. Pregnant women receiving cognitive behavioural
therapy or another individual or group psychological
therapy
2. Pregnant women taking antidepressants
3. Pregnant women suffering from psychosis, current
eating disorder, borderline personality disorder or
current post-traumatic stress disorder, or receiving
care from secondary mental health services
4. Pregnant women who are unable to complete
questionnaires or follow the trial workbook in
English
5. Pregnant women who endorse ‘yes, quite often’
on question ten of the Edinburgh Postnatal
Depression Scale (EPDS) or other measures of
suicidality (e.g. at least two items of the SCID on
suicidality) [25].
Recruitment
Recruitment started in January 2015 and is expected to
be completed by July 2016. The target sample size is 110
women. At the point of submission, a total of 50 women
were recruited to the trial.
Women will be recruited to the trial in one of three
ways:
1. Women attending an antenatal booking clinic in a
South East London maternity service who complete
the Whooley depression screening questions used
routinely in UK maternity services [26] will be
approached by a research midwife and asked to take
part in a related study on wellbeing in pregnancy,
which includes measurement of the prevalence of
depression (REC reference: 14/LO/0075). Women
who consent to take part in the wellbeing in
pregnancy study and who are identified as having
depression on the SCID will be asked by a research
midwife if they would like to take part in this trial.
2. A woman may be referred to the trial by a midwife
in South East London maternity services at a later
point in pregnancy (up to 26 weeks gestation) if the
midwife suspects that the woman is depressed and
may be suitable for the trial. Women can also
self-refer (as happens in routine Improving Access
to Psychological Therapies (IAPT) care); advertise-
ments about the study will be placed in antenatal
clinics, scanning departments and other settings for
local pregnant women, e.g. children’s centres. The
research midwife will administer the baseline mea-
sures to assess eligibility of women for the trial.
3. A woman may self-refer to the trial should she feel
she is experiencing symptoms of depression. An
advertisement for self-referral to the trial will be
positioned in maternity waiting rooms and women’s
booking packs, and the research midwife will adminis-
ter the baseline measures to assess eligibility of
women for the trial.
Assessment of eligibility
The research midwife will outline to women the trial
processes and procedures as described in the participant
information sheet, and answer any questions that arise.
Women will have a minimum of 24 hours to consider if
they wish to participate in the trial.
Randomisation
Women will be randomly assigned to: (1) Guided Self
Help (delivered by a Psychological Wellbeing Practitioner)
plus usual care or (2) usual care alone (i.e. treatment as
usual). Randomisation will be conducted independently of
the trial investigators via the UK Clinical Research Collab-
oration (UKCRC) registered King’s Clinical Trials Unit
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bespoke web-based central randomisation service. Using a
sampling fraction and cut-offs determined from the SCID
instrument, collected during a related study on wellbeing
in pregnancy (REC reference: 14/LO/0075), we will recruit
women in three strata of mild or moderate depression or
mixed anxiety depression. To ensure balance, the web-
based central randomisation service will allocate women
to trial groups (with a 1:1 allocation) using randomly vary-
ing blocks, stratified by severity of depression (assessed
using scores on the SCID depression scale). The block
sizes will not be disclosed, to ensure concealment.
Allocation to trial groups
Once an eligible woman has given her consent and com-
pleted baseline measures, she will be randomised to ei-
ther Guided Self Help plus usual care, or usual care
alone. The research midwife will then communicate in-
formation about the allocation group to the participant
and, for women allocated to Guided Self Help, will ar-
range an appointment with the Psychological Wellbeing
Practitioner (PWP) to start the intervention.
This trial, being embedded within a related population
screening study on wellbeing in pregnancy (REC refer-
ence: 14/LO/0075), will allow us to compare the baseline
and outcomes of those in the treatment-as-usual group
and those receiving treatment as usual though not par-
ticipating in the trial.
See Additional file 3: Figure S2 for a protocol flow
diagram.
Intervention
Guided Self Help interventions for depression
Guided Self Help is delivered within the Improving Ac-
cess to Psychological Therapies (IAPT) programme,
which is a large-scale initiative that aims to increase the
availability of NICE-recommended psychological treat-
ments for depression and anxiety disorders within NHS-
commissioned services in England. It was originally
launched in 2008, and key successes in the first three full
financial years include more than 1 million people enter-
ing treatment, 680,000 people completing treatment and
recovery rates in excess of 45 % (with around 65 %
showing significant improvement) [24]. IAPT is continu-
ing to expand with plans to be available to at least 15 %
of the adult population and to deliver recovery rates of
50 % or more by March 2015 [24].
Two half-time NHS PWPs — Agenda for Change band
five, with a post-graduate diploma in low intensity inter-
ventions — will be seconded from the IAPT programme
and will deliver the trial intervention of Guided Self
Help modified for pregnancy. PWPs are UK NHS health
service employees who deliver evidence-based low inten-
sity cognitive behavioural therapy (CBT) interventions
within the IAPT programme. They have experience in
delivering treatment based on Guided Self Help man-
uals, and in supporting patients’ use of Guided Self Help
manuals and relevant freely available resources through
regular contact. PWPs are used to carrying a high vol-
ume caseload of patients requiring low intensity inter-
ventions, and they are experienced in monitoring
progress and assessing changes in symptoms; they may
signpost to other services if necessary. As part of their
role within the IAPT programme, PWPs are required to
collect a number of standardised measures including the
Patient Health Questionnaire (PHQ-9), Generalised
Anxiety Disorder (GAD-7), the Work and Social Adjust-
ment Scale and Phobia Scales. The PWPs are required
to possess a range of perinatal competencies in order to
successfully deliver the Guided Self Help components of
the trial (see the list of competencies in the Appendix).
Modified Guided Self Help (with usual care) for antenatal
depression
A workbook appropriate for pregnancy (available from
the corresponding author on request) was developed. In
order to establish the components of the intervention, a
literature search was carried out to identify studies on
risk factors for antenatal depression, moderating factors
for poor child outcomes and qualitative studies on
women’s experience of antenatal depression. Following
this process, key components identified included:
1. Psycho-education about the symptoms and causes of
depression with a focus on factors related to
pregnancy
2. An introduction to the cognitive behavioural model
and the links between thoughts, feelings and
behaviours, and cognitive-behavioural strategies for
managing mood, including activity planning, problem
solving and thought challenging
3. Managing relationships in the perinatal period,
including increasing social support,
4. the development of maternal-fetal attachment and
reflecting on how we learn to be parents
5. Health and lifestyle factors, including issues
involving smoking and nutrition
6. Preparing for parenthood.
The workbook was divided into six chapters, each in-
cluding a mixture of educational material, testimonials
from pregnant women and exercises to be completed by
participants. Exercises were based on cognitive behav-
ioural skills, starting with more behavioural interven-
tions such as activity planning and problem solving, and
moving on to more cognitive skills such as thought chal-
lenging and identifying underlying rules for living. At
the end of each chapter a list of homework tasks were
suggested, and throughout the workbook there were
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links to other sources of support, e.g. websites, organisa-
tions which provide support or advice to pregnant
women, children’s centres and antenatal classes.
Recent evidence suggests that a minimum of four ses-
sions is necessary to achieve good rates of change for
low intensity interventions and that dose-response re-
duces after six sessions [27]. The workbook was there-
fore designed to be delivered across six sessions; adding
an introductory session and a final maintenance session
led to an eight-session intervention. Current IAPT prac-
tice is to offer sessions lasting between 30–45 minutes,
either on the telephone or face to face.
During development, drafts of the workbook were sent
to an advisory panel of perinatal experts (psychologists,
psychiatrists and midwives) for comments and feedback.
A draft was also sent to a panel of service users who
were part of an advisory group to a larger perinatal
study. These women provided feedback on wording,
relevance and use of examples and layout, and the work-
book was modified accordingly. The workbook was
piloted by one of the authors (JD) in routine IAPT care;
ten women took part in the pilot to assess the feasibility
of delivering the intervention during pregnancy, the ac-
ceptability of the content to pregnant women and pre-
liminary outcomes. Based on women’s feedback, a
number of amendments were made: the text was edited
to reduce the number of words; the title was changed to
‘Wellbeing in Pregnancy’ (several women commented on
the original title of the workbook, ‘Antenatal Depression’,
which they felt was unhelpful due to possible stigma and
their associations with more severe forms of perinatal
disorders); specific references were made to how differ-
ent sections were relevant to women who already have
children; and the health chapter was adapted to be more
focussed on overcoming barriers to good health be-
haviours (several women felt the chapter on health
repeated messages they had from midwives and had
less of a warm tone than other chapters). Women re-
ported needing the sessions to motivate them and en-
gage with the material; i.e. they indicated that they
may not have completed the workbook on their own.
The routinely collected scores on measures of anxiety
(GAD-7) and depression (PHQ-9 and EPDS) reduced
following the intervention.
Prior to delivering this Guided Self Help intervention
within this pilot RCT, the two PWPs were trained in the
modified intervention (and subsequently supervised on a
weekly basis) by an experienced perinatal clinical psych-
ologist. They were also trained in associated areas rele-
vant to perinatal clinical work including safeguarding,
violence and abuse, smoking cessation and the mother-
child relationship [21]. The two PWPs will collect the
same standardised measures as they would within an
IAPT setting — Patient Health Questionnaire (PHQ-9),
the Generalised Anxiety Disorder scale (GAD-7), the
Work and Social Adjustment Scale and Phobia Scales —
at every Guided Self Help session they have with trial
participants.
The Guided Self Help (with usual care) intervention for
antenatal depression comprises an initial session at the be-
ginning of therapy followed by up to eight 30-minute ses-
sions, delivered weekly where possible. The PWPs will
also conduct an additional session, at six to eight weeks
post-delivery (i.e. before the post-delivery research out-
comes are collected). The first Guided Self Help session
will be delivered face to face, and the subsequent sessions
will either be delivered face to face or over the telephone,
based on the participants’ preferences.
Based on existing evidence from trials of Guided Self
Help [27], a minimum number of four sessions is re-
quired to determine reliable and clinically significant im-
provements. Women who show no improvement in
symptoms at the end of the Guided Self Help sessions
and who want further support will be referred by the
PWP either for high intensity interventions or to their
general practitioner (GP), as is the usual clinical practice.
Women who show significant deterioration in symptoms
on the routinely collected measures — at any point during
or at the end of the Guided Self Help sessions — will be
discussed in the PWPs’ clinical supervision (or in more ur-
gent situations, the nominated senior psychologist avail-
able for emergencies) and referred as appropriate to GPs,
high intensity psychologists or secondary care.
Treatment as usual
The findings of local audits and a recent study [18] indi-
cate that very few pregnant women are referred for psy-
chological therapy in routine practice. We will record
any referrals that occur, treatment received and other in-
terventions accessed (e.g. third sector support, antide-
pressants) for women in both groups of the trial (at the
two follow-up points).
Outcomes
Primary outcome
The primary outcome is the score for Edinburgh Postna-
tal Depression Scale (EPDS) depressive symptoms at
14 weeks post-randomisation.
Key secondary outcomes
At 14 weeks post-randomisation
At 14 weeks post-randomisation, the secondary out-
comes are:
1. Proportion of participants meeting PHQ-9 criteria
for depression (i.e. score of ≥10)
2. Proportion of participants meeting GAD-7 criteria
for anxiety (i.e. score of ≥8).
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At 3 months post-delivery
At 3 months post-delivery, the secondary outcomes are:
1. EPDS score
2. Parenting stress.
See Additional file 4: Table S2 for further details of the
measures and times of assessment.
Measures
Data will be collected at the following time points: base-
line, 14 weeks post-randomisation and 12 weeks post-
delivery (see Additional file 4: Table S2 for a full list of
the study measures). Baseline measures will be collected
by researchers prior to the assignment of participants to
the trial groups. Baseline interviews may take up to
45 minutes if women have been referred to the trial by
clinic midwives or via self-referral; these women will
need to undergo a detailed assessment of their eligibility
for the trial. For women taking part in the related study,
the interview will take between 5 and 8 minutes, as they
will have already completed a detailed assessment of
their eligibility for the trial and will just need to be
asked some additional measures. The 14-weeks post-
randomisation interview may take up to 30 minutes
and the 3-months post-delivery interview up to 40 mi-
nutes. All follow-up measures will be collected by an-
other researcher who will be blind to the allocation
status of the participant. The researcher will ask the
participant not to mention to which group she was
allocated. A test of the success of masking will be
carried out; at the end of each follow-up interview,
the researcher will document his/her views on which
arm of the trial he/she believes participants have been
allocated to. At the end of the trial, we will compare
the actual allocation status of participants against the
researcher’s estimated allocation status to determine
the strength of blinding in the trial.
The following data will be extracted from maternity
records:
1. Mode of delivery; maternal ethnicity; parity and pre-
pregnancy body mass index (estimated at booking);
fetal growth data as available from routine scans
2. Infant outcomes: Apgar scores; birthweight; sex;
gestational age to calculate customised birthweight
centiles adjusted for maternal age; need for
resuscitation; days in neonatal unit; growth weight
and height centiles over first 12 weeks where
available from routine measures in primary care.
The PWPs will also collect data using the PHQ-9 [28],
GAD-7 [29], IAPT Phobia Scale [30] and IAPT Work
and Social Adjustment Scale [31] at each session
delivered to women in the Guided Self Help plus usual
care group, as this is normal practice in all IAPT
services.
Process evaluation
A fidelity rating scale has been developed to rate adher-
ence to the Guided Self Help components by the PWPs.
We aim to audio-record five initial sessions for each
PWP and rate their adherence to the intervention com-
ponents using a checklist corresponding to the content
of the workbook modules. Rating of fidelity will be car-
ried out by two independent psychologists. Further rat-
ings on a random sample of 20 sessions will ensure
quality control and fidelity. The scale was designed to
assess adherence to the key components of the interven-
tion. It includes items such as setting an agenda/orient-
ing the client to the session, discussing questionnaire
scores, covering material from the workbook and
reviewing and setting homework. It was necessary to use
a slightly adapted version of the scale for the first and
last sessions because of intrinsic differences (e.g. there
was no homework to review from a previous session in
the first session). Each item is rated according to its
presence or absence from the session, with the item being
scored if there was any evidence that it had been included.
A rating of 80 % adherence indicates high fidelity.
Additionally, it was thought important to have a meas-
ure of the ability of the PWPs to develop a positive
therapeutic alliance. Research suggests that the relation-
ship between client and therapist is a key variable in re-
lation to therapy outcomes ([32, 33], but see also [34]).
The Cognitive Therapy Scale Revised (CTS-R) [35] is a
widely used and well-validated instrument for evaluating
therapist competency and adherence to CBT principles.
It was not appropriate to use a full CTS-R, because the
intervention was not full cognitive behaviour therapy
but rather a cognitive behaviourally based Guided Self
Help package. Item 5 of the scale concerns ’interpersonal
effectiveness’ defined as ’the ability of the therapist to
form a good relationship with the patient’. This includes
the ability to put the client at ease, to facilitate disclos-
ure of difficult material and to exhibit the nonspecific
factors of empathy, genuineness and warmth delineated
by Carl Rogers [36]. It was decided to use this item of
the scale, rated from 0 to 6, as an indication of the ex-
tent to which PWPs were able to respond to their clients
and build a positive therapeutic alliance. Scores on the
scale should approximate to a normal distribution with a
mid-point of 3, with very high scores reserved for expert
competency, particularly in the face of difficulties. When
the full scale is used, a mean score of 3 on each item is
taken to indicate competency. Because the full scale
could not be used, the ratings provide an indication of
interpersonal effectiveness but do not represent the
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broader picture of CBT competencies assessed by the
full scale. The PWP will also collect data on the mode of
delivery of Guided Self Help sessions (i.e. face to face or
via telephone).
Levels of compliance will be assessed using data col-
lected by the PWPs on the number and length of Guided
Self Help sessions offered and the number of sessions
attended/not attended or cancelled.
Descriptions of treatment as usual will be recorded, in-
cluding the frequency of contact with health/social care
services (using the Adult Service Use Scale (AD-SUS)) at
14 weeks post-randomisation and 12 weeks post-delivery.
Qualitative data will be collected from interviews with
a purposive sample (with respect to ethnicity, age and
parity) of 20 women, after completion of the 3-months
post-delivery research interviews. A brief topic guide will
be used to ask participants for feedback about their ex-
pectations and experiences of participating in the inter-
vention (and/or other care) and using maternity and
primary care services.
Sample size
This is primarily a feasibility trial, but we also carried
out a sample size calculation to allow us to calculate
what preliminary evidence we could generate on efficacy.
Assuming a correlation of 0.4 between baseline and out-
come EPDS symptom score, a two-arm parallel-group
design with 52 women in each arm, the Stata procedure
sampsi gives 79 % power to detect a difference of 0.5 SD
using ANCOVA and a two-tailed test using a 95 % sig-
nificance level (based on an effect size of 0.31, as this
was found in a systematic review of Guided Self Help in
non-maternity settings [22]). We aim to recruit 110
women. The study would have 66 % power to detect a
difference in the caseness rate of recovery of 35 % in
controls versus 60 % in the Guided Self Help arm.
Statistical analysis
Analysis will be by intention to treat; missing data will
be imputed. The planned strategy for handling missing
data at the item and scales will depend on the amount
of missing data observed and the planned analyses for
the outcomes. To ensure the same strategy is followed
across all scales reported in the principle paper(s), any
guidance given by authors of validated questionnaires
will supersede the methods outlined herein.
If any of the baseline measures can be hypothesised to
predict missing scale outcomes, it would be advanta-
geous to include them in the modelling. To allow for
this, any baseline measure considered as a covariate in
the main modelling must be imputed to a full dataset.
Missing baseline covariate item data will be imputed
using mean imputation per participant (pro rating) or
using the ice command in Stata to make a single
imputation. There will be missing data in post-treatment
outcome variables as participants are lost to follow-up.
The regression analyses are based on maximum likeli-
hood, and resulting inferences are valid provided the
missing data generating mechanism is missing at ran-
dom (MAR); that is, missingness is predicted only by
variables that are included in the model, including earl-
ier values of the outcome variable. We will empirically
assess using logistic regression whether any baseline var-
iables predict missingness, and should this be the case,
we would condition on such variables by including them
in the statistical model. Where post-randomisation vari-
ables predict missingness, we will make use of the MAR
properties of (restricted) maximum likelihood random
effects estimators for repeated measures.
Although the main aim of the trial is to assess feasibil-
ity, an exploratory primary outcome analysis will be car-
ried out using a regression of the EPDS depression
symptom score using baseline symptom score as a co-
variate (ANCOVA), with confidence intervals (CIs) cal-
culated using bootstrap. Because the trial is embedded
within a screening study, we will estimate the effect of
the treatment on diagnostic rates of depression in the
pregnant population using multiple imputation from
EPDS symptom scores and screening scores available in
the whole screened population.
An odds ratio and 95 % CI for recovery, defined within
IAPT as a PHQ-9 score of ≥10 at 14 weeks post-
randomisation, will be estimated. We will compare
groups for continuous scores on the EPDS at 14 weeks
post-randomisation and 3 months post-delivery. The
variance estimates will assist in power calculations for a
definitive trial. Supplementary analyses will estimate
complier average causal effects for a binary measure of
compliance to treatment using the instrumental variable
method. Therapist effects will be evaluated. Infant
growth will be explored using random effects growth
curve models (xtmixed in Stata) to compare birth and
growth velocities of the groups.
Qualitative data will be coded in NVivo8 [37] follow-
ing the principles of framework analysis [38], which in-
cludes the identification of a thematic framework, the
abstraction and synthesis of key themes and the map-
ping and interpretation of the dataset as a whole. Quali-
tative results will be discussed within the context of
quantitative data interpretation.
Economic evaluation
The economic evaluation will take the NHS and per-
sonal social services perspective preferred by NICE [39].
Resource use data from the AD-SUS (see Additional file
4: Table S2 for full details of the AD-SUS measure) will
be combined with unit costs to calculate total costs of
the Guided Self Help and usual care groups. The cost of
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Guided Self Help will be calculated using a micro-
costing approach based on the PWPs’ salary, including
relevant on-costs and overheads. Unit costs of other ser-
vices will be taken from national published sources.
Exploratory economic analyses, on an intention-to-treat
basis, will include tests for differences in cost using stand-
ard parametric t tests with the validity of results con-
firmed using bias-corrected, nonparametric bootstrapping
(repeat re-sampling) [40]. Cost-effectiveness will be
assessed through the calculation of incremental cost-
effectiveness ratios [41] and will be explored in terms of
quality-adjusted life years using the SF-6D (derived from
the 36 item Short Form Health Survey (SF-36)). A sensi-
tivity analysis will be performed using the EuroQoL five
dimensions questionnaire (EQ-5D), and a formal assess-
ment of the validity and responsiveness of both the SF-6D
and EQ-5D will be undertaken following standard
methods [42, 43]. All regressions to calculate mean differ-
ences in costs will be repeated with the further inclusion
of covariates for baseline clinical measures. Uncertainty
around the cost and effectiveness estimates will be repre-
sented by cost-effectiveness acceptability curves [44].
Should the results of the trial support the use of Guided
Self Help as an effective and cost-effective treatment
option for mild and moderate antenatal depression,
data from the trial will be used to re-run the eco-
nomic decision model from a related study (WENDY-
http://www.kcl.ac.uk/ioppn/depts/hspr/research/CEPH/
wmh/projects/A-Z/WENDY-well-being-in-pregnancy-
in-an-inner-city-maternity-service.aspx) in order to
explore the relative cost-effectiveness of the alterna-
tive screening approaches when Guided Self Help is
incorporated into the treatment pathway for this
group of women.
Discussion
The DAWN trial is the first exploratory trial to our
knowledge to investigate the efficacy of antenatal Guided
Self Help for pregnant women diagnosed with mild to
moderate depression. As part of a larger National Insti-
tute for Health Research (NIHR)-funded programme of
research (see http://www.kcl.ac.uk/ioppn/depts/hspr/re-
search/CEPH/wmh/projects/A-Z/esmi.aspx), independ-
ent oversight is provided by a Programme Steering
Committee, Programme Data Monitoring and Ethics
Committee (DMEC) and Trial Steering Committee
(TSC). The UKCRC registered King’s College London
(KCL) Clinical Trials Unit provides web-based data
entry systems using the InferMed MACRO data entry
system which is compliant with Good Clinical Practice
(GCP) and Food and Drug Administration (FDA) 21
Code of Federal Regulations (CFR) Part 11. No interim
analyses are planned. Only the trial investigators and
the TSC and DMEC, if any adverse or other unintended
effects are identified, will have access to participants’
personal data. We will collect, assess, report and man-
age any adverse events that may occur. Any adverse
events or other unintended effects of the trial interven-
tion or conduct will be recorded and reported to the
DMEC (DMEC charter available from author).
Ethical issues
A number of practical measures have been taken to min-
imise distress and risk to participants. These include the
following:
1. When taking consent, researchers will explain to
participants that they can take time in answering
questions and do not have to answer questions that
they do not want to.
2. At the baseline interview, researchers will ask
participants if they would like to nominate a
contact for support, should they become distressed.
3. During the interview, researchers will closely
monitor participants for signs of distress and, if
observed, will take appropriate action, including
asking the participant if she would like to take a
short break, skipping questions that cause particular
distress, or offering to complete the interview at
another time.
Safety protocols have been developed to ensure that
participants, their families and the researcher remain
safe when making contact, conducting research and
afterwards. On initial contact, researchers will establish
an appropriate contact number and time for future con-
tact between themselves and participants; if participants
would like to keep their participation in the research
confidential from other people, researchers will establish
how to manage the situation if conversations are over-
heard (e.g. they can start discussing safety of electrical
appliances in the home). This is done because there is a
risk that telephone conversations may still be overheard.
At all points of contact, researchers will confirm that
they are speaking with the participant and will not leave
information with any other household member, unless
the participant has specified that this is okay. The iden-
tity of the researchers will not be given to any caller
until the identity of the caller has been established. Re-
searchers will ensure that the location(s) where an inter-
view takes place is private and secure and cannot be
overheard. Interviews will be conducted either in a se-
cure room at the NHS Trust or, if deemed safe, at the
participant’s home. If interviews are to take place at a
participant’s home, the researcher will first discuss any
immediate or peripheral safety issues with support pro-
viders or relevant professionals and clarify if it is safe for
them to conduct interviews in the home. Researchers
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will have access to a mobile phone and screech alarm at
all times during interviews and will give details of inter-
view locations, start times and approximate end times to
colleagues at their research department. After the inter-
views, researchers will ask the participants how they feel
and if they would like to discuss anything further with
their responsible clinician.
Confidentiality
All participants will be interviewed in private by trained
researchers. The information provided by participants
will be confidential and anonymised. In some situations,
however, it may be necessary to disclose personal infor-
mation without a patient’s consent if it is in the public
interest (i.e. where a failure to do so may expose the pa-
tient or others to risk of death or serious harm). The
limits of confidentiality are explained on the participant
information sheet and will be discussed with all partici-
pants as part of the informed consent process. The Gen-
eral Medical Council guidance on confidentiality will be
followed [45]; disclosure of personal information without
consent may be justified in the public interest where fail-
ure to do so may expose the patient or others to risk of
death or serious harm. In cases where the patient or
others are exposed to a risk so serious that it outweighs
the patient’s privacy interest, consent to disclose will be
sought. If it is not practicable to obtain consent, the in-
formation will be disclosed to an appropriate person or
authority. The researchers will contact one of the clinical
applicants on the grant to discuss any situations when
confidentiality may need to be broken. Detailed guidance
on safeguarding maternal and child welfare is outlined
in the Programme-wide Standard Operating Procedures.
Trial status
The trial is currently recruiting.
Appendix
Psychological Wellbeing Practitioner perinatal
competencies for the DAWN trial
A pre-requisite for working on the trial was that the
Psychological Wellbeing Practitioners (PWPs) had com-
pleted PWP (IAPT) low intensity training and had
acquired a Postgraduate Certificate in Low Intensity Cog-
nitive Behavioural Interventions according to the National
Curriculum for the Education of Psychological Wellbeing
Practitioners (now the 3rd edition, 2015). On appointment
to the trial, the PWPs received training to cover compe-
tencies relevant to working with women during the peri-
natal period, as specified below.
Knowledge of pregnancy, childbirth and the postnatal
period
This competency includes knowledge of:
 Physical and emotional changes during the
perinatal period
 Common complications of pregnancy, childbirth
and the postnatal period
 Routine maternity and obstetric care
Knowledge of mental health during the perinatal period
This competency includes knowledge of:
 Prevalence of mental health problems; risk of
relapse; the impact of mental health problems on
the infant
 Understanding of the importance of prevention and
early intervention and the role of specialist
perinatal mental health services
 Knowledge of depression and anxiety disorders and
how they may present in the perinatal period as
well as how their course can fluctuate in response
to events in the perinatal period
 Knowledge of serious mental health problems and
how they may present in the perinatal period
including bipolar disorder and post-partum psychosis.
Understanding of the parent-infant relationship
This competency involves awareness of issues relating to
infant mental health, attachment and parenting (includ-
ing the ways in which experiences of being parented are
relevant when becoming a parent).
Therapeutic competencies relating to the perinatal period
These competencies include:
 The ability to support women using Guided Self
Help materials with adaptations for the perinatal
period
 Knowledge of behavioural activation that is
appropriate for the woman’s goals, her stage of
pregnancy or for the postnatal period allowing for
taking care of the baby
 Knowledge of relaxation techniques
 Knowledge of Guided Self Help interventions to
increase the availability of interpersonal support
 The ability to work with cognitions and beliefs
about the baby/about self as a parent
 Knowledge of Guided Self Help interventions
relating to health and lifestyle.
Metacompetencies
Metacompetencies include planning and delivering treat-
ment in a flexible manner, including adjusting to un-
anticipated events during pregnancy or postnatally.
Professional, ethical and legal issues
This competency includes:
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 Knowledge of IAPT including criteria for stepping
up and down relevant to the perinatal period
 Knowledge of local specialist perinatal services,
referral routes and care pathways
 Awareness of national and local organisations
relevant to the perinatal period
 Ability to liaise with other agencies such as
maternity services, health visitors and social care
 Knowledge of safeguarding, including assessing and
managing risks to the unborn infant and making
referrals to Social Care
 Ability to administer, score and interpret routine
outcome measures
 Awareness of issues relating to consent and
confidentiality
 Awareness of equality and diversity, including
cultural differences in parenting, same sex couples
and single parents.
DAWN trial induction and specialist training
This training includes:
 Overview of perinatal mental health
 Adaptations of CBT and common themes in the
perinatal period
 Use of the workbook
 Supporting Infant Mental Health
 Safeguarding Children Level 3
 Domestic Abuse Awareness
 Smoking Cessation
 Smoking Cessation in Pregnancy and the
Postpartum Period
 Observing a booking appointment
 Visit to the antenatal and postnatal wards.
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